Home Boronic Acids 1001907-57-8
1001907-57-8,MFCD09870057
Catalog No.:AA00013T

1001907-57-8 | 2-Methyl-2H-indazole-6-boronic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95+%
in stock  
$77.00   $54.00
- +
250mg
95+%
in stock  
$126.00   $89.00
- +
1g
95+%
in stock  
$270.00   $189.00
- +
5g
96%
in stock  
$1,133.00   $794.00
- +
10g
96%
in stock  
$1,866.00   $1,306.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00013T
Chemical Name:
2-Methyl-2H-indazole-6-boronic acid
CAS Number:
1001907-57-8
Molecular Formula:
C8H9BN2O2
Molecular Weight:
175.9803
MDL Number:
MFCD09870057
SMILES:
Cn1cc2c(n1)cc(cc2)B(O)O
Properties
Computed Properties
 
Complexity:
191  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
1  

Downstream Synthesis Route
1001907-57-8    916451-11-1   
C33H37N5O5Si 

[1]Locationinpatent:schemeortableYu,Wensheng;Tong,Ling;Kim,SeongHeon;Wong,MichaelK.C.;Chen,Lei;Yang,De-Yi;Shankar,BandarpalleB.;Lavey,BrianJ.;Zhou,Guowei;Kosinski,Aneta;Rizvi,Razia;Li,Dansu;Feltz,RobertJ.;Piwinski,JohnJ.;Rosner,KristinE.;Shih,Neng-Yang;Siddiqui,M.Arshad;Guo,Zhuyan;Orth,Peter;Shah,Himanshu;Sun,Jing;Umland,Shelby;Lundell,DanielJ.;Niu,Xiaoda;Kozlowski,JosephA.[BioorganicandMedicinalChemistryLetters,2010,vol.20,#17,p.5286-5289]

1001907-57-8   
4-bromo-1-isopropyl-7-methyl-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1H-indole-6-carboxamide 
 
1-isopropyl-7-methyl-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-4-(2-methyl-2H-indazol-6-yl)-1H-indole-6-carboxamide 

[1]CurrentPatentAssignee:PIRAMALENTERPRISESLIMITED-WO2015/104677,2015,A1Locationinpatent:Page/Pagecolumn97

1001907-57-8   
tert-butyl(S)-2-(((2-chloro-5-iodopyridin-4-yl)amino)methyl)morpholine-4-carboxylate 
 
C23H28ClN5O3 

[1]Osborne,JamesD.;Matthews,ThomasP.;McHardy,Tatiana;Proisy,Nicolas;Cheung,Kwai-MingJ.;Lainchbury,Michael;Brown,Nathan;Walton,MichaelI.;Eve,PaulD.;Boxall,KatherineJ.;Hayes,Angela;Henley,AlanT.;Valenti,MelanieR.;DeHavenBrandon,AlexisK.;Box,Gary;Jamin,Yann;Robinson,SimonP.;Westwood,IsaacM.;VanMontfort,RobL.M.;Leonard,PhilipM.;Lamers,MariekeB.A.C.;Reader,JohnC.;Aherne,G.Wynne;Raynaud,FlorenceI.;Eccles,SuzanneA.;Garrett,MichelleD.;Collins,Ian[JournalofMedicinalChemistry,2016,vol.59,#11,p.5221-5237]

7342-82-7    1001907-57-8   
6-(benzobthiophen-3-yl)-2-methyl-2H-indazole 

[1]Goldfogel,MatthewJ.;Guo,Xuelei;MeléndezMatos,JeishlaL.;Gurak,JohnA.;Joannou,MatthewV.;Moffat,WilliamB.;Simmons,EricM.;Wisniewski,StevenR.[OrganicProcessResearchandDevelopment,2022,vol.26,#3,p.785-794]

1001907-57-8    17321-77-6   
N,N-dimethyl-3-(3-(2-methyl-2H-indazol-6-yl)-10,11-dihydro-5H-dibenzob,fazepin-5-yl)propan-1-amine 

[1]Goldfogel,MatthewJ.;Guo,Xuelei;MeléndezMatos,JeishlaL.;Gurak,JohnA.;Joannou,MatthewV.;Moffat,WilliamB.;Simmons,EricM.;Wisniewski,StevenR.[OrganicProcessResearchandDevelopment,2022,vol.26,#3,p.785-794]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1001907-57-8 Molecular Formula|1001907-57-8 MDL|1001907-57-8 SMILES|1001907-57-8 2-Methyl-2H-indazole-6-boronic acid